The the drug treatsa rare pediatric disease D. A. said the most common side effects were respiratory infections and constipation , and there is a warning The F. D. A. platelet counts and toxicity to the kidneys .Even though trial investigators did not know which patient was receiving Spinraza , " anecdotally , it just seemed quickly obvious to us that some patients were following a very different trajectory than what we were used to seeing , " said Dr. John Brandsema of the Children ’s Hospital of Philadelphia , one of the investigators .us said that while the patients who improved were the most remarkable , the drug also appears to stop the progression of the disease Dr. John Brandsema of the Children’s Hospital of Philadelphia, one of the investigators other patients .